21/09/2007 (Agence Europe) - The European Commission has approved smaller strength capsules of anti-flu vaccine Tamiflu manufactured by Roche. 'Smaller strength capsules provide convenient alternative for management of seasonal and pandemic influenza in children,' notes a Roche headline in a press release published on Thursday 20 September. The new smaller capsules have a longer shelf life than the suspension formula and are therefore a better option for government pandemic stockpiling. The...